Radical surgery for early gastric cancer

European Journal of Surgical Oncology

Volumn 24, Issue 4, 1998, Pages 263-266

  Whiting, J L ^a   Fielding, J W L ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

Gastric cancer; Surgery

Indexed keywords

EARLY DIAGNOSIS; GASTRECTOMY; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MINIMAL RESIDUAL DISEASE; PANCREAS RESECTION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SHORT SURVEY; SPLENECTOMY; STOMACH CANCER;

EID: 0031711711     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0748-7983(98)80002-4     Document Type: Note

References (27)

1. Hallissey MT, Allum WH, Jewkes AJ, Ellis DJ, Fielding JW. Early detection of gastric cancer [see comments]. Br Med J 1990; 301: 513-5.
2. Allum WH, Powell DJ, McConkey CC, Fielding JW. Gastric cancer: a 25-year review. Br J Surg 1989; 76: 535-40.
3. Akoh JA, Macintyre IM. Improving survival in gastric cancer: review of 5-year survival rates in English language publications from 1970. Br J Surg 1992; 79: 293-9.
4. Hallissey MT, Dunn JA, Ward LC, Allum WH. The second British Stomach Cancer Group trial of adjuvant radiotherapy and chemotherapy in resectable gastric cancer: five-year follow-up. Lancet 1994; 343: 1309-12.
5. Allum WH, Hallissey MT, Kelly KA. Adjuvant chemotherapy in operable gastric cancer. 5 year follow-up of first British Stomach Cancer Group trial. Lancet 1989; 1: 571-4.
6. Hundahl SA, Stemmermann GN, Oishi A. Racial factors cannot explain superior Japanese outcomes in stomach cancer [see comments]. Arch Surg 1996; 131: 170-5.
7. Yonemura Y, Segawa M, Matsumoto H, et al. Surgical results of performing R4 gastrectomy for gastric cancer located in the upper third of the stomach. Surg Today 1994; 24: 488-93.
8. Cuschieri A, Fayers P, Fielding J, et al. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group [see comments]. Lancet 1996; 347: 995-9.
9. Parikh D. Johnson M. Chagla L, Lowe D, McCulloch P. D2 gastrectomy: lessons from a prospective audit of the learning curve. Br J Surg 1996; 83: 1595-9.
10. Siewert JR, Bottcher K, Roder JD, Busch R, Hermanek P, Meyer HJ. Prognostic relevance of systematic lymph node dissection in gastric carcinoma. German Gastric Carcinoma Study Group [see comments]. Br J Surg 1993; 80: 1015-8.
11. Volpe CM, Koo J, Miloro SM, Driscoll DL, Nava HR, Douglass HO, Jr. The effect of extended lymphadenectomy on survival in patients with gastric adenocarconoma. J Am Coll Surg 1995; 181: 56-64.
12. Pacelli F, Doglietto GB, Bellantone R, Alfieri S, Sgadari A, Crucitti F. Extensive versus limited lymph node dissection for gastric cancer: a comparative study of 320 patients [see comments]. Br J Surg 1993; 80: 1153-6.
13. Bonenkamp JJ, Songun I, Hermans J, et al. Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients [see comments]. Lancet 1995; 345: 745-8.
14. Sue-Ling HM, Martin I, Griffith J, et al. Early gastric cancer: 46 cases treated in one surgical department. Gut 1992; 33: 1318-22.
15. Griffith JP, Sue-Ling HM, Martin I, et al. Preservation of the spleen improves survival after radical surgery for gastric cancer. Gut 1995; 36: 684-90.
16. Wanebo HJ, Kennedy BJ, Winchester DP, Stewart AK, Fremgen AM. Role of splenectomy in gastric cancer surgery: adverse effect of elective splenectomy on longterm survival. J Am Coll Surg 1997; 185: 177-84.
17. Otsuji E, Yamaguchi T, Sawai K, Ohara M, Takahashi T. End results of simultaneous splenectomy in patients undergoing total gastrectomy for gastric carcinoma. Surgery 1996; 120: 40-4.
18. Maehara Y, Moriguchi S, Yoshida M, Takahashi I, Korenaga D, Sugimachi K. Splenectomy does not correlate with length of survival in patients undergoing curative total gastrectomy for gastric carcinoma. Univariate and multivariate analyses. Cancer. 1991; 67: 3006-9.
19. Hisamichi S. Screening for gastric cancer. World J Surg 1989; 13: 31-7.
20. Jatzko GR, Lisborg PH, Denk H, Klimpfinger M, Stettner HM. A 10-year experience with Japanese-type radical lymph node dissection for gastric cancer outside of Japan. Cancer 1995; 76: 1302-12.
21. McCulloch P. Should general surgeons treat gastric carcinoma? An audit of practice and results, 1980-1985. Br J Surg 1994; 81: 417-20.
22. Wu CW, Hsieh MC, Lo SS, et al. Morbidity and mortality after radical gastrectomy for patients with carcinoma of the stomach. J Am Coll Surg 1995; 181: 26-32.
23. Cuschieri A, Weeden S, Fielding J, et al. Patient survival after Dl and D2 resections for gastric cancer: long term results of the MRC randomised surgical trial. (In prep.)
24. Siewert JR, Kestlmeier R, Busch R, et al. Benefits of D2 lymph node dissection for patients with gastric cancer and pN0 and pN1 lymph node metastases. Br J Surg 1996; 83: 1144-7.
25. Ishida K, Katsuyama T, Sugiyama A, Kawasaki S. Immunohistochemical evaluation of lymph node micrometastases from gastric carcinomas. Cancer 1997; 79: 1069-76.
26. Hayes N, Karat D, Scott DJ, Raimes SA, Griffin SM. Radical lymphadenectomy in the management of early gastric cancer. Br J Surg 1996; 83: 1421-3.
27. de Dombal FT, Price AB, Thompson H, et al. The British Society of Gastroenterology early gastric cancer/dysplasia survey: an interim report [see comments]. Gut 1990; 31: 115-20.